TEM
Tempus AI Inc
$82.88
0.00 (0.00%) Today
0.30 (0.36%) Pre-market
— up— down
Market Cap
$14.90B+5.1%
Revenue (TTM)
$1.42B+50.4%
Net Income (TTM)
$-258,500,208
$-258,500,208EPS (TTM)
-1.43
-1.43Shares Out
180.24M
180.24MOpen
$82.58
$82.58Previous Close
$82.58
$82.58Day Range
$81.78 – $89.09
$81.78 – $89.0952-Week Range
$40.77 – $104.32
$40.77 – $104.32Beta
2.29
2.29Volume
6.29M
6.29MAvg Volume
6.71M
6.71MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout TEM
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
Related
News
N/AN/AN/A
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
Yahoo · 1d ago
Tempus AI Receives 510(k) Clearance From FDA For Tempus ECG-MR, AI Product That Analyzes Standard 12-Lead Resting Ecgs To Detect Signs Associated With Undiagnosed Mitral Regurgitation
Benzinga · 2d ago
Tempus AI Chief Accounting Officer Sells $529,650 of Stock
Yahoo · 5d ago